VAYK=starting to move=finally

At least $500,000 profit i would guess.

wtf=say something=what is happening?

https://www.otcmarkets.com/filing/html?id=18480617&guid=CXc-knoP670Wdth

VAYK Projects to Report Over $400K Q1 Revenue
ATLANTA, May 15, 2025 /PRNewswire/ -- Vaycaychella, Inc. (OTC Pink: VAYK) ("VAYK") management announces today that the company is projected to report more than $400,000 in revenue for the first quarter of 2025. The company has filed a late filing notice and is expected to report its financial statements by May 20, 2025.

The Q1 revenue will be more than half of the entire year's revenue from 2024, when the company reported less than $700,000 in revenue for the whole year. The company attributes this to significant growth in demand for its services and is optimistic that the annual revenue may exceed one million dollars.

In addition to service revenue growth, the company confirms that it has started work on the Rufus Rose House project, which will renovate a historic landmark in downtown Atlanta into a boutique short-term rental property. Upon completion, the project may be worth $5–8 million.

The company is also working to launch a disruptive business model in the short-term rental industry. The new business model will integrate real estate development, financial engineering, social accountability, and AI-based short-term rental management.

still nothing

https://www.otcmarkets.com/stock/AXXA/news/Exxe-Advances-Tech-Enabled-Real-Estate-Monetization-Thun-Switzerland?id=471749

https://seekingalpha.com/pr/20046454-st-georges-confirms-the-presence-of-niobium-at-notre-dame

Shareholders
Mar. 12, 2025 7:59 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 12, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH)

Dear Shareholders,

I wanted to issue this brief letter to share a few updates. To start, it's important to note that there are no delays with the NIH or NSF grants. These grants were filed in advance of the January 6th deadline and as a result we are expecting answers in May possibly April. I also received notification that the review process for these grants will start in March. The NIH grant would allow Johns Hopkins University the ability to move forward with clinical trials of our smoke-free low dose dissolvable strip and allow CTT to create the first oral smoking cessation product in 40 years. Additionally, we added two people to the company to help with the NIH and NSF grants. They have extensive knowledge about our technology and have many years of experience with grants.

https://webfiles.thecse.com/SX_Press_Release_-_March_12_2025_-_EVSX_Secures_New_Three-Year_Battery_Supply_Agreement.pdf?6_Vcirkf32xUDN_EJ9QSQ4gPQfbBtlW0

CTT Pharma Uplists to the OTCQB Today
Mar. 09, 2025 6:00 PM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 9, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH) has entered the OTCQB Market today under the ticker symbol "CTTH". CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025.

SXOOF=Finally they can start doing something to make money.

https://seekingalpha.com/pr/20023811-evsx-receives-final-environmental-compliance-approval

Announces Uplisting to OTCQB Market Trading
Mar. 05, 2025 7:15 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.

https://www.otcmarkets.com/stock/VAYK/news/VAYK-Proposes-100-million-Buyback-through-Private-Repurchases?id=469227

CTT Pharmaceutical Holdings, Inc
@CTT_Pharma
·
2h
The OTC indicated to CTT Pharma that we will be getting more information about our uplisting to the OTCQB by early next week. CTT also found out this week that our NIH and NSF grants are not delayed.

It is only a matter of time-my guess is a few months - before they have revenue.Than it should take off.

https://seekingalpha.com/pr/20012653-ctt-pharma-gives-update-on-u-s-and-european-patents

this could move fast=months of news = little movement = so far

https://seekingalpha.com/pr/19994822-lithium-pilot-plant-project-receives-contribution-from-federal-government

CTTH=Keep in mind that they have under 57 million outstanding shares and only just over 23 million float.

CTTH = this company is moving fast toward a deal or at least getting grant money.imo

https://seekingalpha.com/pr/19992121-ctt-pharma-adds-independent-director-with-nih-nsf-experience

Feb. 03, 2025 7:15 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the authorized share count from 300 million shares to 150 million shares. This change has already been filed with Delaware Division of Corporations. Furthermore, CTT's stock issuer has been notified and made the necessary corrections to reflect this change. This latest adjustment demonstrates CTT Pharma's ongoing commitment to optimizing its capital structure and delivering long-term value to shareholders. CTT is also in the process of gaining approval to uplist to the OTCQB and believes this decision benefits existing and future shareholders.

look close

did you miss this or just beginning to move

https://www.otcmarkets.com/stock/ARRKF/news/Arras-Minerals-Drills-868-Metres--110-GT-AUEQ-from-Surface-at-Berezski-East-Target---Elemes-Project-Kazakhstan?id=466059

really not sure if this is news or repeating news

https://www.stocktitan.net/news/IPNFF/imagine-ar-introducing-ai-ar-as-a-service-platform-transforming-70k678gd429d.html

Now 71%

What What=53% gain in one day!

only just begun

OTC Disclosure & News Service
CTT Pharma will issue a news release January 22, 2025

https://www.otcmarkets.com/stock/ARRKF/news/Arras-Minerals-Drills-261-Metres--064-CuEq-In-First-Holes-at-Berezski-Central-Target---Elemes-Project-Kazakhstan?id=464760

$15,000,000 would be a lot for this company to work with.

https://seekingalpha.com/pr/19961230-ctt-pharma-and-johns-hopkins-university-submits-proposal-for-15-million-nih-grant-for-smoking

this could be huge

CTTH -
CTT Pharmaceutical Holdings, Inc
@CTT_Pharma
·
40m
CTT Pharma will update shareholders January 7, 2025 on partnership with Johns Hopkins University.